Close Menu

NEW YORK (GenomeWeb) – Somalogic said today it has entered a collaboration with Janssen Research & Development to analyze clinical samples using its SomaScan proteomics platform.

Under the agreement, Somalogic will measure roughly 5,000 proteins in at least 15,000 clinical samples to discover and validate protein markers to help predict, diagnose, monitor, and treat disease including rheumatoid arthritis, inflammatory bowel disease, lupus, and cardiovascular and metabolic conditions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Mainichi reports that 43 percent of Japanese individuals said they did not want to eat agricultural products that had been modified using gene-editing tools.

Two US Department of Agriculture research departments are moving to the Kansas City area, according to the Washington Post.

Slate's Jane Hu compares some at-home genetic tests to astrology.

In PLOS this week: analysis of polygenic risk scores for skin cancer, chronic pain GWAS, and more.